For global cosmetic companies planning to place whitening, brightening, pigmentation-care, or dark spot products on the Chinese market, the first compliance question is not how to translate the claim, but whether the product falls within China whitening cosmetics registration as a special cosmetic. In China, freckle-removing and whitening cosmetics require pre-market registration with the National Medical Products Administration (NMPA) before domestic production or importation. The registration outcome depends on the consistency of the product classification, formula, functional ingredient evidence, safety assessment, efficacy substantiation, testing sequence, and label claims.
According to the 2025 cosmetics technical evaluation report released by the National Institutes for Food and Drug Control (NIFDC), freckle-removing and whitening products, including products that achieve whitening effects only through physical coverage, accounted for 43.4% of accepted cosmetic registration applications. This makes the category one of the key areas of special cosmetics review in China.
REACH24H helps global cosmetic brands assess product classification, review formula and ingredient compliance, prepare safety and efficacy evidence, and complete NMPA special cosmetics registration before market entry.
What Are Freckle-Removing and Whitening Cosmetics in China?
Under China’s cosmetics classification rules, freckle-removing and whitening cosmetics refer to products that help reduce or slow skin pigmentation and achieve a whitening effect, or products that achieve a whitening effect through physical coverage. Products intended to improve acne marks caused by pigmentation may also fall within this category.
However, not every product positioned as “brightening,” “radiance-boosting,” “tone-evening,” or “anti-dullness” is automatically classified as a whitening cosmetic in China. Product classification should be assessed based on the product’s actual function, mechanism of action, formula, and claim wording.
For example:
Products that improve skin brightness only through hydration, cleansing, or exfoliation are different from freckle-removing and whitening cosmetics in terms of their main mechanism of action.
Products that only contain sunscreen agents, without freckle-removing or whitening agents, should not directly claim freckle-removing or whitening effects.
For overseas brands, product positioning used in the EU, US, UK, Korea, Japan, or ASEAN markets may need to be reassessed before China market entry. A claim that appears acceptable in another jurisdiction may trigger special cosmetics registration requirements in China if it implies pigmentation reduction, whitening, or freckle-removing effects.
China Whitening Cosmetics Registration Process and Timeline
Freckle-removing and whitening cosmetics are classified as special cosmetics in China. Under the Cosmetic Supervision and Administration Regulation (CSAR), such products must obtain NMPA registration before they can be produced domestically or imported into China.
In practice, the full registration process usually takes approximately 6–10 months, depending on product readiness, testing progress, dossier quality, and technical review questions. The process generally includes the following stages.
1. Pre-registration Preparation
Pre-registration preparation is the foundation of a successful application and usually takes around 4–6 months. Companies should complete a structured review of the product before formal submission, including:
Formula and packaging compliance review;
Ingredient compliance and safety information review;
Microbiological, physicochemical, and toxicological testing;
Human safety and efficacy evaluation;
Product safety assessment report preparation;
Registration dossier compilation.
Before conducting human safety and efficacy evaluation, the product should first complete microbiological, physicochemical, and toxicological testing, and written reports should be issued. If these preliminary test items fail, the product should not proceed to human safety and efficacy evaluation.
For freckle-removing cosmetics, if the human skin patch test shows irritation or the result is difficult to determine, an additional repeated open application test may be required.
2. Application Submission and Acceptance Review
The registrant submits the full registration dossier through the NMPA cosmetics registration and notification information platform. The acceptance authority conducts a formal review within 5 working days. If the application materials are complete and meet the formal requirements, the application will be accepted.
3. Technical Review
The technical review period is 90 working days. During this stage, the review authority conducts a substantive assessment of the product’s safety, efficacy claim substantiation, ingredient evidence, test results, and dossier consistency.
If the review authority identifies deficiencies, it will issue a one-time request for supplementary materials. The registrant must complete the supplement and resubmit the materials within 90 working days. Failure to submit the supplementary materials within the required period will result in the application being deemed not approved in the technical review.
4. Administrative Approval and Registration Certificate
After the product passes technical review, the NMPA makes an administrative approval decision within 20 working days and issues the special cosmetics registration certificate.
The registration certificate is valid for five years. The registrant may apply for renewal within six months before the expiry date.
Common Reasons for NMPA Registration Failure
For freckle-removing and whitening products, the main registration risk is not only whether the required tests and documents are submitted, but whether the entire evidence chain is scientifically consistent. The following issues commonly lead to supplementary requests, dossier revision, repeated testing, or technical review failure.
1. Insufficient Study on Whitening Mechanism and Safety
For whitening functional ingredients that have clear regulatory use references or mature market applications in other countries or regions, companies still need to prepare supporting materials in line with China’s regulatory requirements. These materials may include the ingredient’s mechanism of action, safety basis, quality control information, and relevance to the finished product formula.
For whitening agents with a weaker evidence basis, a more systematic study may be required. When conducting research on freckle-removing and whitening ingredients, companies should ensure that:
The mechanism study is based on the actual use level in the formula;
The selected efficacy indicators have a clear relationship with the whitening effect;
The mechanism of action is not confused with sunscreen, cleansing, exfoliating, or moisturizing effects;
The synergistic effect and possible safety risks of multiple whitening ingredients are scientifically explained;
Test interference from other substances is reasonably controlled and explained.
2. Lack of Characteristic Quality Control Indicators
For non-single-component ingredients, such as certain botanical extracts used as whitening functional ingredients, the ingredient safety information should include characteristic quality control indicators that reflect ingredient quality.
Where applicable, this may include quantitative requirements for specific functional components. These indicators help demonstrate the long-term stability, consistency, safety, and efficacy relevance of the ingredient.
3. Inappropriate Safety Assessment Basis
For freckle-removing and whitening ingredients, companies should not rely on ingredient use information from marketed products published by regulatory authorities or a three-year history of use as the safety assessment basis. This type of evidence is not accepted for the safety assessment of freckle-removing and whitening ingredients.
Global brands should therefore review whether their ingredient evidence is suitable for China’s safety assessment requirements before dossier preparation begins.
4. Non-compliant Testing Sequence
Companies should complete microbiological, physicochemical, and toxicological testing before conducting human safety and efficacy evaluation.
If the preliminary tests are not completed first, or if any preliminary test fails, the subsequent human test results may not be usable for registration purposes. This may result in additional testing, dossier rework, or failure during technical review.
5. Product Category Does Not Match the Actual Formula
A whitening cosmetic that claims to achieve whitening only through physical coverage should be consistent with this declared mechanism.
If the formula also contains chemical whitening functional ingredients and the product has an actual chemical whitening effect, it should not be registered under the category of freckle-removing products that work only through physical coverage.
6. Label Claims Are Inconsistent with the Mechanism of Action
Label claims should be consistent with the product classification, formula design, mechanism of action, and efficacy evaluation materials.
For example, a product that works only through physical coverage should not claim that continuous use can achieve a biological whitening effect. Such inconsistency may create review concerns and increase the risk of supplementary requests or rejection.
Impact and Actionable Advice for Global Cosmetic Companies
For multinational cosmetic companies, freckle-removing and whitening products require earlier regulatory planning than many ordinary cosmetics. The key compliance challenge lies in aligning product development, testing, registration strategy, and marketing claims before submission.
Companies planning to launch whitening, brightening, pigmentation-care, or dark spot products in China should take the following actions:
Conduct product classification assessment before finalizing the claim strategy. Terms such as “brightening,” “dark spot correction,” “radiance,” or “even skin tone” should be reviewed together with the formula and mechanism of action.
Review whitening functional ingredients early. Ingredient safety data, quality control indicators, and mechanism evidence should be checked against China’s requirements before testing and dossier preparation.
Build a complete evidence chain. The formula, efficacy mechanism, test endpoints, safety assessment, efficacy evaluation, and label claims should support the same product positioning.
Plan the testing sequence carefully. Microbiological, physicochemical, and toxicological testing should be completed before human safety and efficacy evaluation.
Avoid direct transfer of overseas claims. Claims accepted in other markets may not be suitable for China if they imply freckle-removing or whitening effects without sufficient supporting evidence.
Review the Chinese label as a regulatory document, not only a marketing asset. For this product category, label wording can directly affect product classification and technical review.
Before submitting an NMPA registration application, companies should confirm the following points:
Whether the product falls within the scope of freckle-removing and whitening special cosmetics;
Whether the formula and functional ingredients support the claimed effect;
Whether the safety assessment basis is acceptable for China registration;
Whether characteristic quality control indicators are available for relevant functional ingredients;
Whether the efficacy evaluation supports the proposed claim wording;
Whether the label claims match the product’s actual mechanism of action;
Whether the testing sequence complies with the registration requirements.
Addressing these issues before submission can help reduce supplementary requests, repeated testing, dossier rework, and technical review failure.
How REACH24H Supports China Whitening Cosmetics Registration
REACH24H provides full-process regulatory support for global cosmetic companies entering the Chinese market, with extensive experience in special cosmetics registration and high-risk product categories such as freckle-removing and whitening cosmetics.
Pre-registration Assessment
Product classification assessment;
China regulatory pathway analysis;
Formula and ingredient compliance review;
Whitening functional ingredient evidence review;
Ingredient safety information and submission code review;
Packaging and Chinese label compliance review.
Testing and Evidence Strategy
Testing strategy and testing sequence review;
Microbiological, physicochemical, and toxicological testing coordination;
Human safety and efficacy evaluation plan review;
Whitening mechanism and efficacy evidence review;
Safety assessment data gap analysis;
Characteristic quality control indicator review.
NMPA Registration Dossier Support
Product safety assessment report preparation or review;
Special cosmetics registration dossier preparation;
Registration application material review;
Online submission support through the NMPA cosmetics registration and notification information platform;
Communication support during the registration process.
Supplementary Response and Post-registration Support
Technical review comments analysis;
Supplementary response strategy;
Supplementary material preparation;
Registration renewal support;
Change management;
Cancellation support;
Post-market compliance maintenance.
Why Choose REACH24H?
With a team of cosmetics regulatory specialists, toxicologists, safety assessors, risk assessment experts, and multilingual consultants, REACH24H helps companies identify compliance risks before submission and improve the completeness, consistency, and defensibility of their NMPA registration dossiers
Global Service Network
With 9 global branches and over 300 in-house specialists, we have served over 15,000 enterprises including 103 Fortune Global 500 firms, delivering prompt cross-border regulatory support.
Decades of Cosmetic Compliance Expertise
Backed by long-standing compliance experience and expert resources, we customize full-spectrum solutions covering regulatory planning and cosmetic safety evaluation. Recognized by top brands, Fortune 500 enterprises and industrial associations, we help clients resolve compliance hurdles and smoothly access global cosmetic markets.
Globally Accredited Toxicology Experts
We have a team with over 20 certified toxicologists holding China Toxicologist, US DABT and EU ERT credentials to underpin cosmetic safety assessment and registration submission.
FAQ: China Whitening Cosmetics Registration
Get Your Whitening Cosmetic Assessed Before NMPA Submission
China’s NMPA registration requirements for whitening and freckle-removing cosmetics are highly technical. Early assessment can help global brands choose the correct regulatory pathway, prepare sufficient evidence, and avoid avoidable review risks.
REACH24H can help assess product classification, formula compliance, whitening functional ingredient evidence, efficacy claim substantiation, safety assessment gaps, testing strategy, and Chinese label risks before formal submission.
Official Regulatory Resources
National Medical Products Administration (NMPA) – official English portal of China’s drug and cosmetics authority.
NMPA Cosmetics section – official cosmetics regulatory updates and announcements.
The Provisions for Registration and Filing of Cosmetics – official English version of the key registration and filing rules.
Cosmetic Classification Rules and Categories – NMPA announcement on product classification rules and coding requirements.
NMPA policy interpretation on cosmetic safety assessment – official interpretation covering safety assessment requirements and higher-risk products.
Related Insight and Service Resources
For readers who want a detailed explanation of the regulatory process, see REACH24H’s related insight article: How to Register Whitening and Spot-Removing Cosmetics in China.
You may also find the following REACH24H service pages useful:

